حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Deva Holding AS
DEVADeva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary systems, connective tissue, and sensory organs; and veterinary medicines. In addition, the company offers various products in sterile and non-sterile forms, including liquids, semi-solids, solids, cephalosporins, penicillin, hormone and inhalation products, solid and liquid oncology, animal health products, active pharmaceutical ingredients, ampoules, liquid and lyophilized vials, eye drops, medical ampoules for sterile injectable products, and cologne. It also exports its products to approximately 50 countries. The company was incorporated in 1958 and is based in Istanbul, Turkey. Deva Holding A.S. is a subsidiary of Eastpharma S.à R.L. Address: Halkali Merkez Mah., Istanbul, Turkey, 34303
Analytics
سعر الهدف في وول ستريت
114.63 TRYنسبة السعر إلى الأرباح
4.8443العائد الربحي
0.37 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية DEVA
تحليلات الأرباح DEVA
نمو الأرباح على مدى 5 سنوات
–النمو المستمر
1 سنةمعدل الدفع 5 سنوات في المتوسط
2 %تاريخ الأرباح DEVA
تقييم الأسهم DEVA
المالية DEVA
نتائج | 2019 | ديناميات |